Patent · US Expired

Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments

US7012099B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Bernd Sundermann · Aachen, DE
Stephan Wnendt · Aachen, DE
Werner Englberger · Stolberg, DE

Key dates

Filing date	Dec 20, 2000
Grant date	Mar 14, 2006
Priority date	—
Expiry date	May 13, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of substituted 4-amino-1-phenylbutan-2-ol compounds in the form of their racemates, enantiomers, diastereomers or corresponding bases or corresponding salts of physiologically acceptable acids as regulators for the nociceptin/orphanin-FQ ligand ORL1 receptor system and for the production of medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.